International Evaluation of Radiotherapy Technology Effectiveness in Cervical Cancer (INTERTECC) is a study run by an international network of institutions committed to scientific testing of new radiation technologies to improve cancer care. Researchers from around the globe participate in this collaborative clinical trial.
The study is a Phase II/III trial to test the impact of intensity modulated radiation therapy (IMRT) on the treatment of cervical cancer.
For more information on INTERTECC, please contact Loren Mell, MD. You can also see a list of affiliated People and Centers, or links to Protocol and Instructions.